CHLA-15Homo sapiens (Human)Cancer cell line
Also known as: CHLA15, CHLA_15
AI Summary
No AI-generated summary available for this cell line.
Basic Information
| Database ID | CVCL_6594 |
|---|---|
| Species | Homo sapiens (Human) |
Donor Information
| Age | 1 |
|---|---|
| Age Category | Pediatric |
| Sex | Female |
| Race | unknown |
Disease Information
| Disease | Neuroblastoma |
|---|---|
| Lineage | Peripheral Nervous System |
| Subtype | Neuroblastoma |
| OncoTree Code | NBL |
DepMap Information
| Source Type | Academic lab |
|---|---|
| Source ID | ACH-001300_source |
Haplotype Information (STR Profile)
Short Tandem Repeat (STR) profile for cell line authentication.
Amelogenin
X
CSF1PO
10,12
D13S317
10,11
D16S539
11,13
D18S51
15,19
D19S433
14,15
D21S11
30,31.2
D2S1338
17,26
D3S1358
16
D5S818
12,15
D7S820
9,11
D8S1179
13
FGA
23,24
TH01
6,7
TPOX
8
vWA
16,17
Gene Expression Profile
Gene expression levels and statistical distribution
Loading cohorts...
Full DepMap dataset with combined data across cell lines
Loading gene expression data...
Publications
Alternative lengthening of telomeres in neuroblastoma cell lines is associated with a lack of MYCN genomic amplification and with p53 pathway aberrations.
Lau L.M.S.
J. Neurooncol. 119:17-26(2014).
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma.
Vogelstein B., Kinzler K.W., Velculescu V.E., Hogarty M.D.
Nat. Genet. 45:12-17(2013).
Drug resistance patterns of human neuroblastoma cell lines derived from patients at different phases of therapy.
Keshelava N., Seeger R.C., Groshen S., Reynolds C.P.
Cancer Res. 58:5396-5405(1998).